Get started
Author

Erika Giordani

Observed names: E Giordani, E. GIORDANI, E. Giordani, GIORDANI, ERIKA
OpenAlex ID: A5108568333
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study
2013 · Luigi Rossi, Federica Tomao, et al. · Therapeutics and Clinical Risk Management · 14
PDF
An unusual case of spleen metastasis from carcinoma ex pleomorphic adenoma of the parotid gland
2014 · Luigi Rossi, Erika Giordani, et al. · World Journal of Surgical Oncology · 10
PDF
Emerging Role of Cetuximab in the Treatment of Colorectal Cancer
2012 · Anselmo Papa, Luigi Rossi, et al. · Recent Patents on Anti-Cancer Drug Discovery · 9
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
2012 · Luigi Rossi, Federica Zoratto, et al. · OncoTargets and Therapy · 8
PDF
From conventional chemotherapy to targeted therapy: use of monoclonal antibodies (moAbs) in gastrointestinal (GI) tumors
2014 · Federica Zoratto, L. Rossi, et al. · Tumor Biology · 3
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D).
2014 · Monica Verrico, Luigi Rossi, et al. · Journal of Clinical Oncology · 1
Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100).
2014 · ANSELMO PAPA, Luigi Rossi, et al. · Journal of Clinical Oncology · 1
Incidence of chemotherapy (CT)-induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T).
2012 · Enrico Basso, Luigi Rossi, et al. · Journal of Clinical Oncology · 1
Abstract PS3-09-18: Early AB-ITALY: Evaluating Real-World Use of Adjuvant Abemaciclib and Drug Interaction Risk in HR+/HER2- early Breast Cancer
2026 · S. Scagnoli, M. Verrico, et al. · Clinical Cancer Research
Abstract P4-01-19: Liquid biopsy and re-biopsy: Tracking mutational trajectories in HER2+ breast cancer patients undergoing T-DM1 treatment
2019 · M Allegretti, E Giordani, et al. · Cancer Research
Management of breakthrough cancer pain (BTcP) in patients with bone metastases of solid tumors
2016 · G.P. Spinelli, E. Gozzi, et al. · Annals of Oncology
PDF
Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100 +/- docetaxel: comparison of efficacy and tolerability between lenograstim and pegfilgrastim
2015 · L. Rossi, A. Papa, et al. · Annals of Oncology
PDF
Oral Vinorelbine as single agent in the treatment of poor Performance Status (pPS) metastatic Non Small Cell Lung Cancer (NSCLC): a single institution experience
2015 · G.P. Spinelli, V. Stati, et al. · Annals of Oncology
Efficacy, safety, and cost-effectiveness (CE) analysis of pegfilgrastim (P) and lenograstim (L) in patients (pts) with nonmetastatic breast cancer (nmBC) receiving myelosuppressive chemotherapy (mCT).
2012 · Anselmo Papa, Luigi Rossi, et al. · Journal of Clinical Oncology
“Long extended” temozolomide in a selected population with not radically resected high-grade gliomas.
2012 · Gian Paolo Spinelli, Giuseppe Lo Russo, et al. · Journal of Clinical Oncology
Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts).
2012 · Luigi Rossi, Federica Tomao, et al. · Journal of Clinical Oncology
382 Efficacy, Safety Profiles and Cost-effectiveness Analysis of Pegfilgrastim and Lenograstim in Patients with Non Metastatic Breast Cancer Receiving Adjuvant Myelosuppressive Chemotherapy
2012 · L. Rossi, G. Lo Russo, et al. · European Journal of Cancer
ChemInform Abstract: Carbohydrate Natural Products as a Scaffolding for the Preparation of Potential Neuraminidase Inhibitors.
1997 · A. M. MAIONE, E. GIORDANI, et al. · ChemInform
Works count: 29
Citation count: 47
H-index: 4
I10-index: 2
Year
Topic
Type